SCHEMBL6023907

SCHEMBL6023907

COc1cc(C(=O)C=CN2CCN(CCc3ccc(Cl)cc3)CC2)cc(OC)c1O

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DHCR7 Q9UBM7 1/20 0.48
MAPK1 P28482 2/20 0.48
ALDH1A1 P00352 3/20 0.47
MAPT P10636 2/20 0.47
NPC1 O15118 1/20 0.47
USP2 O75604 1/20 0.47
LMNA P02545 1/20 0.47
ABCB1 P08183 5/20 0.47
EBP Q15125 3/20 0.42
SIGMAR1 Q99720 3/20 0.42
POLB P06746 2/20 0.42
GAA P10253 2/20 0.42
KDM4E B2RXH2 2/20 0.42
ABCG2 Q9UNQ0 2/20 0.41
TMEM97 Q5BJF2 1/20 0.41
EBPL Q9BY08 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6023912 0.78 ACHE (0.56) MAPK1ABCB1GAAMEN1KMT2A
SCHEMBL9513235 0.73 KMT2A (0.67) MAPK1ALDH1A1MAPTLMNAPOLB
SCHEMBL6022511 0.73 ALDH1A1 (0.44) MAPK1ALDH1A1MAPTNPC1USP2
SCHEMBL6022502 0.71 ADRA1D (0.39) MAPK1ALDH1A1MAPTNPC1USP2
SCHEMBL6022899 0.71 SPHK1 (0.40) MAPK1ALDH1A1MAPTNPC1USP2
SCHEMBL2485395 0.70 MEN1 (0.49) MAPK1ALDH1A1MAPTNPC1USP2
SCHEMBL5029884 0.70 ALDH1A1 (0.71) MAPK1ALDH1A1MAPTNPC1USP2
SCHEMBL9514318 0.70 POLB (0.82) MAPK1ALDH1A1NPC1LMNAPOLB
SCHEMBL4376039 0.69 KDM2B (0.51) ALDH1A1MAPTLMNAPOLBGAA
SCHEMBL9512958 0.68 DRD2 (0.60) ALDH1A1LMNASIGMAR1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078407-B2 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2006-07-18 US disclosed
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them HTT, PARK7, NQO1 DHCR7 579/4885MAPK1 2652/4885ALDH1A1 804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.